| Name | ethyl 3,6-dimethylimidazo[2,1-b][1,3]thiazole-5-carboxylate |
|---|---|
| Synonyms |
3,6-Dimethyl-imidazo[2,1-b]thiazol-5-carbonsaeure-aethylester
ethyl 3,6-dimethylimidazo<2,1-b>thiazole-5-carboxylate 3,6-dimethyl-imidazo[2,1-b]thiazole-5-carboxylic acid ethyl ester |
| Molecular Formula | C10H12N2O2S |
|---|---|
| Molecular Weight | 224.27900 |
| Exact Mass | 224.06200 |
| PSA | 71.84000 |
| LogP | 2.18930 |
| HS Code | 2934100090 |
|---|
|
~%
86932-95-8 |
| Literature: ACTELION PHARMACEUTICALS LTD Patent: WO2009/16560 A2, 2009 ; Location in patent: Page/Page column 77 ; WO 2009/016560 A2 |
|
~%
86932-95-8 |
| Literature: Ochiai Chemische Berichte, 1936 , vol. 69, p. 1650,1652 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |